---
category: news
title: "Castle Biosciences Publishes DecisionDx®-Melanoma Study on the Validation of the i31-GEP SLNB Artificial Intelligence Algorithm"
excerpt: "Castle announced the publication of a study validating performance of the i31-SLNB algorithm to determine sentinel lymph node biopsy positivity risk."
publishedDateTime: 2021-11-06T01:00:00Z
originalUrl: "https://www.businesswire.com/news/home/20211105005811/en/Castle-Biosciences-Publishes-DecisionDx®-Melanoma-Study-on-the-Validation-of-the-i31-GEP-SLNB-Artificial-Intelligence-Algorithm"
webUrl: "https://www.businesswire.com/news/home/20211105005811/en/Castle-Biosciences-Publishes-DecisionDx®-Melanoma-Study-on-the-Validation-of-the-i31-GEP-SLNB-Artificial-Intelligence-Algorithm"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "40ca/uSsNcKWgYbUhsw9umuGi4+pRBJu3LirriW17Zz7UvY/HW9QGP2xkirpOJY3ykmjGic6MyRsSQ99kMSrgOfwxGgZFKpGouez9k/+eYRnvE0Gu2qzaMsTVhUKG1VAG4u8dPS0mwN/wxNxSZdW1SVu4HpsQCyzKvvgdRMYejzcxa+4fwymNgIhgql1pSTNy5QuvJTWjVs1yamgqgVINcFdDPRgoBvR94tggNP/5IOL9JmU1MZZQ9avbF43KXPL2vFrdB5M6wVpFY36MA8tYjDEfCH+w0HDVSC/F5nRiHGmYfhM1znBungJrM2VHBLaUQOl+Qb/Dlvf9ucSF87U1LzFHko9W0uLrh7Vdj35lDo=;hlbU6gLn3HXCvrkwTK/TZg=="
---

